BIMI:NSD-Bimi International Medical Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 1.32

Change

+0.20 (+17.86)%

Market Cap

USD 0.02B

Volume

0.09M

Analyst Target

USD 12.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-23 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
WBA Walgreens Boots Alliance Inc

-0.16 (-0.87%)

USD 14.83B
HITI High Tide Inc

-0.18 (-7.53%)

USD 0.18B
PETS PetMed Express Inc

-0.02 (-0.33%)

USD 0.10B
MEDS Trxade Group Inc

+0.22 (+3.91%)

USD 8.10M
CJJD China Jo-Jo Drugstores Inc

+0.44 (+17.21%)

USD 5.41M
LFLY Leafly Holdings Inc

-0.09 (-4.50%)

USD 4.37M
LFLYW Leafly Holdings Inc

-0.01 (-28.87%)

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing BIMI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -39.73% 38% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.73% 38% F 13% F
Trailing 12 Months  
Capital Gain 67.09% 88% B+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.09% 88% B+ 90% A-
Trailing 5 Years  
Capital Gain -99.34% 25% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.34% 25% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -24.91% 67% D+ 15% F
Dividend Return -24.91% 67% D+ 15% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 290.66% 11% F 6% D-
Risk Adjusted Return -8.57% 89% A- 36% F
Market Capitalization 0.02B 63% D 15% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector